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Abstract
Introduction
Effective strategies are needed to reach and treat people who lack awareness of or have uncontrolled hypertension. We 
used data from a community-based participatory research initiative, Hub City Steps, to quantify the prevalence of 
undiagnosed hypertension and determine the relationship between hypertension status at baseline and 
postintervention improvements in blood pressure and health-related quality of life.
Methods
Hub City Steps was a 6-month preintervention–postintervention lifestyle intervention targeting hypertension risk 
factors. Outcome measures were collected at baseline, 3 months, and 6 months. Generalized linear mixed models were 
used to test for effects by time and hypertension status.
Results
Of the enrolled sample (N = 269), most were overweight or obese (91%), African American (94%), and women (85%). 
When considering hypertension status, 42% had self-reported diagnosis of hypertension (self-reported subgroup; 84% 
with antihypertensive medication use); 36% had no self-reported medical history of hypertension, but when blood 
pressure was measured they had a clinical diagnosis of prehypertension or hypertension (undiagnosed subgroup); and 
22% had no self-reported or clinical hypertension diagnosis (no hypertension subgroup). From baseline to 6 months, 
systolic blood pressure significantly improved for participants with self-reported hypertension [8.2 (SD, 18.2) mm Hg] 
and undiagnosed hypertension [12.3 (SD, 16.3) mm Hg], with undiagnosed participants experiencing the greatest 
improvements (P < .001). Effects remained significant after controlling for covariates. Health-related quality of life 
significantly improved for all 3 hypertension subgroups, with no apparent subgroup differences.
Conclusion
This study reveals advantages of a culturally appropriate community-based participatory research initiative to reach 
those with undetected hypertension and effectively improve blood pressure status and health-related quality of life.
Introduction
The overall prevalence of hypertension in the United States is estimated at 34%, with a disproportionate prevalence 
among African Americans (44%) (1). Hypertension is a leading risk factor for cardiovascular and cerebrovascular 
events and a leading cause of morbidity and mortality (1,2). Furthermore, annual health-care expenditures for 
hypertension are approximately $131 billion (3).
To complicate issues related to the high prevalence, racial disparities, cultural disparities, and higher health care costs, 
hypertension has also been termed a silent epidemic. Because hypertension can be asymptomatic, people often do not 
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seek medical care, leaving it undetected and untreated. Likewise, even among those who are aware and treated, rates 
for uncontrolled hypertension are high. For example, the Centers for Disease Control and Prevention (CDC) examined 
awareness and pharmacologic treatment of uncontrolled hypertension (4) in the United States. Using National Health 
and Nutrition Examination Survey (NHANES) data sets and weighted population counts for 2003 through 2010, an 
estimated 66.9 million adults have hypertension, of which 35.8 million (54%) have uncontrolled hypertension. Among 
those with uncontrolled hypertension, an estimated 39% are not aware of their hypertension status, 16% are aware but 
untreated, and 45% are aware and treated.
Hub City Steps was a lifestyle intervention targeting hypertension risk factors in Hattiesburg, Mississippi. Hattiesburg 
includes about 47,000 residents, of which approximately 53% are African Americans and 42% are whites (5). Data 
from NHANES and Behavioral Risk Factor Surveillance System indicate that the prevalence of hypertension is 44% for 
women and 40% for men in Forrest County (6). Likewise, hypertension unawareness is approximately 18% among 
both women and men (6).
All phases of Hub City Steps were guided by community-based participatory research (CBPR) principles (7,8). CBPR 
aims to build equitable community–academic partnerships and promote community participation in all aspects of the 
research process (7,8). CBPR is recognized as a key strategy for translating research into practice that can help in 
reducing health disparities (9). Overarching research goals of this CBPR initiative were to 1) develop and assess 
community capacity to promote physical activity and healthy food choices (10), 2) test treatment effects of a 6-month 
CBPR lifestyle intervention on systolic blood pressure (SBP) among community participants (11,12), and 3) test the 
dose effects of 4 versus 10 follow-up motivational interviewing contacts on SBP over a 12-month maintenance phase. 
Given the emphasis on overall health within the Hub City Steps intervention, another objective of this CBPR initiative 
was to understand health-related quality of life (HRQOL) (13).
We sought to quantify the prevalence of undiagnosed hypertension and determine the relationship between 
hypertension status at baseline and postintervention improvements in blood pressure using data at 3 and 6 months. 
We focus on 3 subgroups, those with 1) self-reported diagnosis of hypertension, with or without antihypertensive 
medication use (self-reported subgroup); 2) no self-reported medical history of hypertension, yet measured clinical 
diagnosis of pre-hypertension or hypertension (ie, SBP greater than 120 or diastolic blood pressure [DBP] greater than 
80 mm Hg) (undiagnosed subgroup); and 3) no self-reported or clinical diagnosis of hypertension (no hypertension 
subgroup). A secondary aim was to examine changes in HRQOL.
Methods
This research was approved by the University of Southern Mississippi’s Institutional Review Board. Before study 
enrollment, written informed consent was obtained from participants. Guided by CBPR principles, a community 
advisory board composed of 21 local stakeholders, 8 academic members, and 3 community intervention staff was 
organized to advise on all aspects of the study design and implementation. Details on the composition and role of the 
community advisory board have been previously published (10,11). A series of 4 community conversations were also 
held with 25 community members. The goal of these conversations was to elicit input on several aspects of intervention 
planning, including recruitment of walking coaches and participants, retention of participants, intervention design, 
scheduling and format of education sessions, and data collection procedures. Summaries were provided to the research 
staff, and recommendations were incorporated into the research protocols. 
Study design
The first phase of Hub City Steps was a 6-month preintervention–postintervention experimental intervention targeting 
hypertension risk factors conducted during January through August 2010. Theory and methods are described 
elsewhere (11,12). In brief, Hub City Steps integrated concepts from several theoretical frameworks including social 
support (14), self-determination theory (15), and the transtheoretical model of change (16). The lifestyle intervention 
consisted of 4 primary components. The first component was 3 sessions of one-on-one motivational enhancement, a 
type of motivational interviewing that uses a feedback approach (17). These 20-minute sessions were provided by 
trained intervention staff at baseline, 3-month, and 6-month data collection points. The second component consisted 
of social support provided by walking group volunteer leaders who were community members designated as “coaches.” 
These coaches were trained to encourage walking, goal setting, and submission of pedometer diaries within walking 
groups. Coaches also served as liaisons between participants and research staff. The third component consisted of self-
monitoring with a pedometer diary. Participants were asked to wear the provided pedometer (Yamax model SW-701, 
Yamax Corporation, Tokyo, Japan) on the waist during waking hours and record their daily steps on weekly pedometer 
diary (postage-paid postcards) or by logging in to the intervention’s website. The fourth component consisted of five 90
-minute monthly education sessions that included principles of the Dietary Approaches to Stop Hypertension (DASH) 
(18) and incorporated group physical activity and sharing of successes and challenges.
Recruitment and eligibility
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The research goal of this lifestyle intervention and primary outcome of interest was blood pressure reduction. Yet in 
working through the CBPR process in coordination with the mayor’s Get Healthy Hattiesburg initiative, it was 
apparent that restricting intervention participation to people with a medical hypertension diagnosis would exclude 
community members who also could benefit from the lifestyle intervention. For this reason, eligibility and recruitment 
efforts were aimed at reaching the broader community by emphasizing health and social opportunities of participating 
in Hub City Steps. Benefits included forming community walking groups and using local health promotion resources, 
such as walking tracks and trails in parks and other locations. Hub City Steps was widely publicized in Hattiesburg by 
using flyers, local media coverage (radio, television, newspaper), and word of mouth. Community awareness was 
further aided through strategic efforts promoting visibility at community and civic events (eg, the Hattiesburg Council 
of Neighborhoods quarterly meeting and the city-sponsored annual Night Out Against Crime community kick-off). 
Coaches were directed to recruit 10 to 12 participants for their team, and this emerged as the primary method by which 
participants were enrolled. Coaches were encouraged to communicate both the social and broad health benefits of 
participating in Hub City Steps. Although recruitment efforts were primarily directed toward African American 
residents, race or ethnicity was not an exclusion criterion. Eligibility criteria included 18 years of age or older, English 
speaking, noninstitutionalized, and resident of the Hattiesburg area, without regard to hypertension status or 
antihypertensive medication use. However, for safety reasons, screened individuals with blood pressure of 180/110 
mm Hg or higher were directed to obtain immediate medical attention and were disqualified from participating.
Outcome measures
Outcome measures were collected at the baseline, 3 months, and 6 months. The primary blood pressure outcomes 
were measured using standardized assessment procedures with an Omron HEM-907XL automatic inflation 
sphygmomanometer (Omron Group, Lake Forest, Illinois). The Omron was programmed to take 2 blood pressure 
measurements at a 1-minute interval and display the average reading. The measure was repeated a second time, 2 
minutes after the first reading, and if the 2 average readings were within 10 mm Hg, the lowest reading was recorded; 
if not, a third measure was taken. Participants were instructed to have no caffeine, tobacco, or exercise for 1 hour 
before blood pressure assessment. Questionnaires were used to assess demographics, medical history, medication use, 
fasting, and smoking. A single item for perceived general health from the CDC’s Healthy Days measure was used to 
measure HRQOL (19). Other anthropometric, biological, and behavioral outcomes were collected and are reported 
elsewhere (11). Participants were compensated $15, $20, and $25, respectively, for their time involved in data 
assessments at the 3 successive time points.
Data analyses
All statistical analyses were performed using SAS software, version 9.3 (SAS Institute Inc, Cary, North Carolina). The 
significance level of the tests was set at .05. Descriptive statistics were used to summarize demographic characteristics 
by hypertension status. Chi-squared tests of association (categorical variables) and analysis of variance (continuous 
variables) were used to compare baseline demographic characteristics among hypertension status subgroups.
Generalized linear mixed models, using maximum likelihood estimation, were used to test for effects of time and 
hypertension status on blood pressure and HRQOL. Maximum likelihood estimation was used to handle missing data 
in the repeated measures (20). Because of recognized limitations of computational complexity and relative instability 
of multiple imputations (20), imputations of missing data were not performed. Time (3 months and 6 months) was 
modeled as a repeated measure by using a variance components covariance matrix structure. We first modeled blood 
pressure changes by using time and hypertension status only as predictor variables, initially including all participants 
with available data and then excluding those who reported a medication change. We subsequently included 
demographic and baseline variables (ie, age, marital status, educational attainment, income status, and baseline body 
mass index) to determine if hypertension status remained a significant predictor of blood pressure changes in the 
presence of covariates. An interaction term for age and hypertension status was also included because of the age 
differences apparent among the hypertension subgroups at baseline. Race, sex, and smoking status were not included 
in these models because of the low proportions of men, current smokers, and races other than African American. 
Interpretation of results based on such small subsets of participants is difficult and can be misleading. Least squares 
means were computed to estimate and compare blood pressure changes, with Tukey-Kramer adjusted P values used 
for multiple group comparisons. This study was powered (80% power; α of .05) to detect a moderate effect size of 0.4 
(difference of 6 [SD, 15] mm Hg between groups) for SBP at 18 months while controlling for 6-month intervention 
treatment effects.
Results
In total, 345 participants expressed interest and were screened for the study, of whom 269 (78%) were enrolled. Of 
those enrolled, most were overweight or obese (91%), African American (94.4%), and women (85.1%), with a mean age 
of 44.3 (SD, 12.2) years (Table 1). When considering hypertension status, 113 (42%) had a self-reported diagnosis of 
hypertension, of whom 95 (84%) reported taking prescribed antihypertensive medication; 97 (36%) had no self-
reported medical history of hypertension, yet when blood pressure was measured had a clinical diagnosis of 
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prehypertension or hypertension (ie, undiagnosed subgroup); and 59 (22%) had no self-reported or clinical diagnosis 
of hypertension. Sex, race, marital status, educational attainment, income, and HRQOL did not differ significantly by 
hypertension status at baseline. However, participants with self-reported diagnosis of hypertension were older, had a 
higher body mass index, and were more likely to self-report a diagnosis of high blood glucose or high cholesterol. 
Those with no self-reported or clinical diagnosis of hypertension were more likely to be current smokers.
Table 2 details blood pressure changes by subgroup of hypertension status at baseline and, separately, changes by 
excluding those who had antihypertensive medication changes. Across both the systolic and diastolic models, blood 
pressure significantly improved from baseline to 6 months for participants with self-reported hypertension and those 
with undiagnosed hypertension, but not among those with no hypertension. There was a significant group effect (P
< .001), such that participants with self-reported hypertension and those with undiagnosed hypertension experienced 
significantly greater improvements in SBP compared with the subgroup with no hypertension. Subgroup analyses were 
similar for the DBP models, with the exception that participants with undiagnosed hypertension also experienced 
significantly greater improvements compared with the other 2 subgroups. The nonsignificant time effect indicates that 
the decreases apparent at 3 months were not different from those at 6 months. When the 8 participants who reported a 
change in antihypertensive medication use were removed from the data set, interpretation of the subgroup analysis did 
not change.
When controlling for time, age, marital status, education status, income, and baseline body mass index, differences in 
blood pressure changes among subgroups remained significant with magnitudes greatest for the undiagnosed 
hypertension subgroup (SBP, −13.9; DBP, −6.4), followed by the subgroup with self-reported diagnosis of 
hypertension (SBP, −7.9; DBP, −3.4). Because time was not significant in these models, the changes represent average 
(3 months and 6 months together) intervention changes. Although none of the covariates were significant in the DBP 
model, age, income, body mass index, and education were significant in the SBP model. Average decreases in SBP were 
2.0, 0.6, and 0.3 mm Hg, respectively, for every 10 years increase in age, 1 unit ($5,000) increase in income, and 1 
kg/m increase in body mass index at baseline. Furthermore, both education groups had significant average decreases 
in SBP, though the magnitude of change in the group with less than high school or high school graduate level of 
education (9.1 mm Hg) was significantly larger than the magnitude of change in the group with some college or a 
college degree (4.9 mm Hg).
Health-related quality of life improved by 0.2 (standard error of mean [SEM], 0.06; P < .001), 0.2 (SEM, 0.07; P
= .02), and 0.3 (SEM, 0.08; P = .002) points, respectively, for the self-reported hypertension, undiagnosed 
hypertension, and no hypertension subgroups. In the HRQOL model, improvements apparent at 3 months were not 
different from those at 6 months; therefore, these reported changes represent average intervention changes. Changes 
among hypertension subgroups were not significantly different from one another.
Discussion
Effective strategies are needed to recruit, engage, and intervene with people who have undetected and uncontrolled 
hypertension (21). These secondary analyses of participants’ baseline hypertension status from a CBPR-guided lifestyle 
intervention reveal findings that can inform potential solutions for addressing the silent hypertension epidemic. 
Although recruitment and inclusion criteria were not restricted to people with hypertension, the prevalence of 
hypertension in the enrolled sample was 78%, of whom 42% had self-reported hypertension and 36% were unaware of 
their clinical diagnosis of prehypertension or hypertension. Although it is difficult to make precise comparisons 
because of methodologic differences, the hypertension prevalence and lack of awareness found in Hub City Steps are 
about double the Forrest County estimates for hypertension prevalence (ie, 44% women, 40% men) and unawareness 
(ie, 18% for both women and men) (6). This finding suggests that setting unrestrictive eligibility criteria and using 
recruitment strategies that focused more broadly on the health and social opportunities of programs were effective 
approaches for reaching people at risk.
The 36% who were unaware of their hypertension experienced the largest blood pressure improvements, indicating 
those most in need of effective hypertension treatment benefited the most from this lifestyle intervention. Additionally, 
most (84%) of those with self-reported hypertension reported prescribed antihypertensive medication use, yet also saw 
significant improvements over the course of the intervention. Because the statistical or clinical interpretations did not 
change after excluding the low proportion of participants that reported changes in antihypertensive medication, it is 
reasonable to assume that medication change did not confound the significant blood pressure reductions from this 
lifestyle trial. Given the persistence of hypertension unawareness and problems with medical care access in health-
disparate regions, it is unlikely that primary care–based treatment approaches alone can adequately reach and engage 
populations in most need of behavioral lifestyle changes to mitigate hypertension risk factors (22).
All subgroups had improvement in HRQOL, even the subgroup without hypertension that did not otherwise benefit 
from blood pressure improvements. This finding is congruent with other studies that have demonstrated 
improvements in quality of life among participants enrolled in behavioral lifestyle interventions (23,24). Quality of life 
2
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is an effectiveness indicator that can provide a critical participant-centered evaluation indicating the effect of program 
delivery practices (13).
If the CBPR efforts of the Hub City Steps lifestyle intervention had applied a recruitment and inclusion or exclusion 
protocol similar to PREMIER and DASH, the success at reaching those with undetected hypertension or those with 
treated but uncontrolled hypertension may have been diminished. Both the PREMIER and DASH trials provide 
effective strategies for the treatment and control of hypertension (25–27). These nonpharmacological, lifestyle trials 
were originally tested through clinical or primary care settings and under highly controlled conditions with strict 
participant inclusion and exclusion criteria (eg, antihypertensive medication use was an exclusion criterion). A number 
of CBPR trials have begun to translate evidence-based hypertension interventions into community-based settings, with 
success in enrolling both women and men (28,29). However, there remains a great need to understand effective 
strategies and protocols to promote recruitment and engagement of community residents into programs that can assist 
with hypertension control, especially for people who are either unaware of their hypertension status or who are aware 
but lack control (4,21).
This study is not without limitations: it was not specifically designed or powered to detect effects based on subgroup 
analysis. For example, race, sex, and smoking status could not be used as covariates in the multivariable models 
because of small sample sizes. However, the P values presented in Table 2 indicated sufficient power to detect effects 
among post-hoc groups and lessen concerns that may have existed if the analysis had revealed null effects. 
Nonetheless, the high proportion of women limits generalizability of findings. Furthermore, the classifications for 
hypertension status were made based on a single day’s measure and not based on at least 2 high readings at 2 different 
times, the suggested standard for diagnosis (30). Finally, only 1 of 4 items from the CDC’s Healthy Days measure was 
used to measure HRQOL (19). Although this may limit generalizability and comparison with other studies, it does not 
diminish the significant preintervention–postintervention improvements realized for this intervention. Additional 
analytical efforts are under way to understand changes in other program outcomes, such as diet and physical activity, 
and to examine how program adherence influences changes in outcomes.
Evaluation of culturally appropriate community-based efforts is needed to understand how to reach the high 
proportion of people with undetected and uncontrolled hypertension. The Hub City Steps initiative provides insight 
into use of such approaches to reach and enroll people in effective lifestyle programs for hypertension control. 
Recognizing the significant improvements realized in blood pressure and HRQOL in this intervention, others may be 
able to apply our CBPR approach to guide community-driven efforts addressing hypertension.
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Tables
Table 1. Characteristics of Hub City Steps Participants and Comparisons 
Between Subgroups of Hypertension Status at Baseline, Mississippi, 2010
Characteristic
All 
Participants 
(N = 269)
Self-Reported 
Diagnosis of 
Hypertension 
(Group A) (n = 
113)
No Self-Reported 
Hypertension, But 
Clinical Diagnosis of 
Prehypertension or 
Hypertension (Group B) 
(n = 97)
No Self-Reported or 
Clinical Diagnosis of 
Prehypertension or 
Hypertension (Group 
C) (n = 59) P
Sex, n (%)
Male 40 (14.9) 19 (16.8) 17 (17.5) 4 (6.8)
.14
Female 229 (85.1) 94 (83.2) 80 (82.5) 55 (93.2)
Race, n (%)
African American 254 (94.4) 108 (95.6) 91 (93.8) 55 (93.2)
.77
White 14 (5.2) 4 (3.5) 6 (6.2) 4 (6.8)
American 
Indian/Alaska 
Native
1 (0.4) 1 (0.9) 0 (0.0) 0 (0.0)
Marital status, n (%)
Married 113 (42.0) 44 (38.9) 49 (50.5) 20 (33.9)
.09
Widowed 12 (4.5) 10 (8.9) 1 (1.0) 1 (1.7)
Divorced 47 (17.5) 20 (17.7) 13 (13.4) 14 (23.7)
Separated 8 (3.0) 6 (5.3) 0 (0.0) 2 (3.4)
Never married 89 (33.1) 33 (29.2) 34 (35.1) 22 (37.3)
Education, n (%)
12 (4.5) 7 (6.2) 2 (2.1) 3 (5.1) .06
a b
c
d
e
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Characteristic
All 
Participants 
(N = 269)
Self-Reported 
Diagnosis of 
Hypertension 
(Group A) (n = 
113)
No Self-Reported 
Hypertension, But 
Clinical Diagnosis of 
Prehypertension or 
Hypertension (Group B) 
(n = 97)
No Self-Reported or 
Clinical Diagnosis of 
Prehypertension or 
Hypertension (Group 
C) (n = 59) P
Less than high 
school graduate
High school 
graduate or 
general 
equivalency 
diploma
41 (15.2) 23 (20.4) 12 (12.4) 6 (10.2)
Some college 74 (22.7) 24 (21.2) 30 (30.9) 20 (33.9)
College degree or 
higher
142 (28.3) 59 (52.2) 53 (54.6) 30 (50.9)
Annual household income, $, n (%)
<10,000 40 (14.9) 22 (19.5) 8 (8.3) 10 (16.9)
.11
10,000–19,999 36 (13.4) 16 (14.2) 12 (12.5) 8 (13.6)
20,000–29,999 54 (20.1) 20 (17.7) 22 (22.9) 12 (20.3)
30,000–39,999 37 (13.8) 14 (12.4) 14 (14.6) 9 (15.3)
40,000–49,999 30 (11.2) 13 (11.5) 10 (10.4) 7 (11.9)
≥50,000 71 (26.5) 28 (24.8) 30 (31.3) 13 (22.0)
Other self-reported cardiovascular disease risk factors, n (%)
Current smoker 23 (8.6) 9 (8.0) 4 (4.1) 10 (17.0) .02
Diagnosed high 
blood glucose
42 (15.6) 30 (26.6) 6 (6.2) 6 (10.2) <.001
Diagnosed high 
cholesterol
52 (19.3) 33 (29.2) 14 (14.4) 5 (8.5) .002
Age, y, mean 
(SD)
44.3 (12.2) 48.6 (12.0) 41.8 (11.8) 39.9 (10.5) <.001
Body mass 
index (kg/m ), 
mean (SD)
34.7 (8.1) 36.1 (8.6) 34.2 (8.0) 32.7 (7.0) .03
Health-related 
quality of life,
mean (SD)
2.9 (0.9) 3.1 (0.9) 2.9 (0.8) 2.8 (1.0) .08
Abbreviation: SD, standard deviation.
No self-reported medical history of hypertension at baseline, but had a measured systolic blood pressure >120 mm Hg or 
diastolic blood pressure >80 mm Hg (ie, clinical prehypertension or hypertension).
P value for differences among groups.
Categories collapsed to African American vs others for comparison purposes.
Categories collapsed to married vs others for comparison purposes.
Categories collapsed for comparison purposes to less than high school or high school graduate vs some college or college 
graduate.
Treated as continuous variable (12 categories in $5,000-step increments).
Pairwise comparison: group B < group C.
Pairwise comparison: groups A > groups B and C.
Pairwise comparison: group A > group C.
Self-reported health status, treated as continuous variable (1 = excellent, 5 = poor).
a b
f
g
h
h
h
2
i
j
a
b
c
d
e
f
g
h
i
j
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Table 2. Blood Pressure Changes by Subgroup of Hypertension 
Status at Baseline and Antihypertensive Medication Changes, 
Mississippi, 2010
Hypertension Group n
Baseline Value 
(n = 269), 
Mean (SD)
Change From 
Baseline to 3 
Months (n = 227), 
Mean (SD)
Change From 
Baseline to 6 
Months (n = 190), 
Mean (SD)
P
time
P
group
All participants with available data
Systolic blood pressure
Self-reported diagnosis of 
hypertension (group A)
113 132.4 (18.9) −7.5 (16.1) −8.2 (18.2)
.45 <.001
No self-reported, yet clinical 
diagnosis of prehypertension or 
hypertension (group B)
97 131.1 (14.9) −10.8 (14.0) −12.3 (16.3)
No diagnosis of hypertension 
(group C)
59 105.3 (8.5) 3.5 (12.7) 2.1 (11.1)
Diastolic blood pressure
Self-reported diagnosis of 
hypertension (group A)
113 86.0 (12.1) −2.9 (11.4) −4.0 (11.9)
.14 <.001
No self-reported, yet clinical 
diagnosis of pre-hypertension 
or hypertension (group B)
97 87.2 (9.7) −5.4 (10.6) −7.8 (10.2)
No diagnosis of hypertension 
(group C)
59 71.2 (8.3) 1.6 (9.4) 0.5 (7.9)
Excluding 8 participants with hypertension medication changes
Systolic blood pressure
Self-reported diagnosis of 
hypertension (group A)
106 131.3 (18.7) −7.0 (15.9) −7.8 (17.6)
.37 <.001
No self-reported, yet clinical 
diagnosis of pre-hypertension 
or hypertension (group B)
96 130.8 (14.7) −10.4 (13.7) −12.3 (16.3)
No diagnosis of hypertension 
(group C)
59 105.3 (8.5) 3.5 (12.7) 2.1 (11.1)
Diastolic blood pressure
Self-reported diagnosis of 
hypertension (group A)
106 85.5 (11.9) −3.0 (10.8) −3.8 (11.9)
.36 <.001
No self-reported, yet clinical 
diagnosis of pre-hypertension 
or hypertension (group B)
96 87.1 (9.6) −5.3 (10.6) −7.8 (10.2)
No diagnosis of hypertension 
(group C)
59 71.2 (8.3) 1.6 (9.4) 0.5 (7.9)
Abbreviation: SD, standard deviation.
Participant categorization at baseline.
Bolded values represents significant changes from baseline at P ≤ .05.
At 3 months, retention rates were 87% (98/113), 81% (79/97), and 85% (50/59) for groups A, B, and C, respectively.
At 6 months, retention rates were 73% (83/113), 66% (64/97), and 73% (43/59) for groups A, B, and C, respectively.
Change from baseline to 3 months compared with change from baseline to 6 months.
Pairwise comparison: groups A and B < group C.
No self-reported medical history of hypertension at baseline, but had a measured systolic blood pressure >120 mm Hg or 
diastolic blood pressure >80 mm Hg (ie, clinical prehypertension or hypertension).
Pairwise comparison: B < A < C.
a b,c b,d e
f
g
h
g
f
g
h
g
a
b
c
d
e
f
g
h
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